JeromePSchartmanMD

PubMed

• Early surgical displacement of submacular hemorrhage without tissue plasminogen activator use: one-year outcomes.
  Marwan Abdulaal, Richard Donkor, Jacobi Robertson, Shawn Lewis, David G Miller
  Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie. 2024-10-01
• 9 citations
  Switching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular d...
  Joseph M Coney, Ryan Zubricky, Samriddhi Buxy Sinha, Nina Sonbolian, Lujia Zhou
  International Journal of Retina and Vitreous. 2023-02-01
• One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents.
  Joseph M Coney, Jasmyne E McCoy, Samriddhi Buxy Sinha, Nina Sonbolian, Lujia Zhou
  Clinical Ophthalmology. 2023-01-01

Journal Articles

• Persistent macular thickening after ranibizumab treatment  
  Bressler SB, Ayala AR, Bressler NM, Melia M, Qin H, Ferris FL 3rd, Flaxel CJ, Friedman SM, Glassman AR, Jampol LM, Rauser ME; Diabetic Retinopathy Clinical Research Ne..., JAMA Ophthalmol, 1/1/2016
• Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema  
  Diabetic Retinopathy Clinical Research Network, Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, ..., N Engl J Med, 1/26/2015
• Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial  
  Writing Committee for the Diabetic Retinopathy Clinical Research Network, Gross JG, Glassman AR, Jampol LM, Inusah S, Aiello LP, Antoszyk AN, Baker CW, Berger BB, Bres..., JAMA, 1/13/2015
• Repeated intravitreous ranibizumab injections for diabetic macular edema and the risk of sustained elevation of intraocular pressure or the need for ocular hypotensive...  
  Bressler SB, Almukhtar T, Bhorade A, Bressler NM, Glassman AR, Huang SS, Jampol LM, Kim JE, Melia M; Diabetic Retinopathy Clinical Research Network Investigators, JAMA Ophthalmol, 1/1/2015
• Ciliary neurotrophic factor (CNTF) for macular telangiectasia Type 2 (MacTel): Results from a phase I safety trial  
  Chew EY, Clemons TE, Peto T, Sallo FB, Ingerman A, Tao W, Singerman L, Schwartz SD, Peachey NS, Bird AC; MacTel-CNTF Research Group, Am J Ophthalmol, 1/1/2015
• Neovascular AMD: treatment beyond anti-VEGF  
  Rao LJ, Coney JM, Schartman JP, Singerman, LJ, Physician, 1/1/2014
• Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy  
  Diabetic Retinopathy Clinical Research Network, JAMA Ophthalmol, 1/1/2013
• Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results  
  Diabetic Retinopathy Clinical Research Network, Elman MJ, Qin H, Aiello LP, Beck RW, Bressler NM, Ferris FL 3rd, Glassman AR, Maturi RK, Melia M, Diabetic Retinopathy Clinical Research Network, Elman MJ, Qin H, Aiello LP, Beck RW, Bressler NM, Ferris FL 3rd, Glassman AR, Maturi RK, Melia M, 1/1/2012
• Pegaptanib octasodium for the treatment of diabetic macular oedema  
  Schartman JP, Coney JM, Miller DG, Expert Opinion on Pharmacotherapy, 1/1/2011
• Comparison of film and digital fundus photographs in eyes of individuals with diabetes mellitus  
  Gangaputra S, Almukhtar T, Glassman AR, Aiello LP, Bressler N, Bressler SB, Danis RP, Davis MD; Diabetic Retinopathy Clinical Research Network, Invest Ophthalmol Vis Sci, 1/1/2011
• Advancing treatments for diabetic macular edema  
  Coney JM, Schartman JP, Singerman LJ, Retinal Physician, 1/1/2011
• Factors associated with visual acuity outcomes after vitrectomy for diabetic macular edema: Diabetic Retinopathy Clinical Research Network  
  Flaxel CJ, Edwards AR, Aiello LP, Arrigg PG, Beck RW, Bressler NM, Bressler SB, Ferris FL 3rd, Gupta SK, Haller JA, Lazarus HS, Qin H, Retina, 1/1/2010
• Anti-VEGF therapy for age-related macular degeneration  
  Schartman JP, Beer PM, Falk NS, Contemp Ophthalmol, 1/1/2008
• How to manage vision loss in retinitis pigmentosa  
  Schartman JP, Scott IU, Eye-net: Ophthalmic Pearls, 1/1/2006
• Re: Intermittent disconjugate gaze: a novel finding in nonalcoholic steatohepatitis  
  Schartman JP, Weinstein J, Hepatology, 1/1/2006
• Join now to see all

Abstracts/Posters

• Impact of Lucentis on psychological morbidity in patients with macular edema and neovascularization secondary to retinal vein occlusion
  Singerman LJ, Himmelman DR, Singerman B, Thomas A, Newman L, Coney JM, Schartman JP, Novak MA, Association for Research in Vision and Ophthalmology Annual Meeting, Fort Lauderdale, FL, 1/1/2012
• SALVAGE Study (NCT00467935): Intravitreal ranibizumab for treatment of advanced macular dysfunction in patients with disciform fibrosis due to exudative AMD
  Lemanski N, Schartman JP, Beer PM, Falk NS, Hartman CL, American Academy of Ophthalmology Annual Meeting, San Francisco, CA, 1/27/2009
• Surgical treatment of central serous chorioretinopathy complicated by total retinal detachment
  Schartman JP, Beer PM, Giganti MF, Falk NS, Retina Congress: combined meeting of the American Society of Retina Specialists, the Macula Society, and the Retina Society, New York, NY, 1/1/2009
• Intravitreal infliximab for retinal diseases: preliminary report of a phase one clinical trial
  Beer PM, Schartman JP, Falk NS, American Society of Retina Specialists (ASRS) Annual Meeting, Maui, HI, 1/1/2008
• Intravitreal ranibizumab for the treatment of disciform age-related macular degeneration: the SALVAGE study
  Lemanski N, Schartman JP, Falk NS, Hartman C, Beer PM, American Society of Retina Specialists (ASRS) Annual Meeting, Maui, HI, 1/1/2008
• Incidence of adverse effects with intravitreal triamcinolone: 20 mg versus 4 mg
  Gloth J, Falk NS, Schartman JP, Beer PM, American Society of Retina Specialists (ASRS) Annual Meeting, Maui, HI, 1/1/2008
• Intravitreal ranibizumab for the treatment of disciform age-related macular degeneration: the SALVAGE study, Interim results
  Lemanski N, Schartman JP, Falk NS, Hartman C, Beer PM, Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Fort Lauderdale, FL, 1/1/2008
• Outcomes of pneumatic retinopexy versus scleral buckling for rhegmatogenous retinal detachment repair in patients with good presenting visual acuity
  Schartman JP, Scott IU, Gardner TW, Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Fort Lauderdale, FL, 1/1/2007
• Prevalence of cystoid macular edema in patients with diabetic clinically significant macular edema
  Schartman JP, Quillen DA, Passantino K, Antonetti D, Gardner TW, Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, Fort Lauderdale, FL, 1/1/2006
• Join now to see all

Lectures

• Update on OCT for Retinal Disease 
  Cleveland, OH - 1/18/2015
• Update on surgical outcomes 2014 
  Cleveland, OH, 2014; Beachwood, OH, 2014 - 1/30/2014
• Diabetes and catarct surgery 
  Cleveland, OH - 1/14/2014
• Polypoidal choroidal vasculopathy 
  Cleveland, OH - 1/15/2013
• Choroidal neovascularization 
  Beachwood, OH - 1/14/2013
• Retinal update on anti-VEGF therapy 
  Vermilion, OH - 1/20/2012
• Exudative retinal detachment in ocular inflammation and uveitis 
  Cleveland, OH - 1/14/2012
• Interesting retinal cases: clinical assessment and management 
  Westlake, OH - 1/5/2012
• Uveitis: evaluation and management 
  Westlake, OH - 1/28/2011
• Retinal imaging 
  Cleveland, OH - 1/26/2011
• Latest technology for age-related macular degeneration (AMD) 
  Warrensville Heights, OH - 1/23/2011
• Latest technology in treating macular degeneration 
  Eastlake, OH - 1/13/2011
• Serous retinopathy 
  Beachwood, OH - 1/3/2011
• Interesting retinal cases 
  Beachwood, OH - 1/25/2010
• Update on retinal surgery 
  Westlake, OH - 1/19/2010
• Case report: central serous retinopathy with total retinal detachment 
  Cleveland, OH - 1/12/2010
• New technology in the treatment of retinal degenerations 
  Cleveland, OH - 1/13/2009
• Technology in age-related macular degeneration 
  Beachwood, OH - 1/1/2009
• Macular and retinal diseases 
  Albany, NY - 1/1/2009
• Complications of intravitreal steroids 
  Buffalo, NY - 1/1/2008
• Surgical treatment of central serous chorioretinopathy complicated by total retinal detachment 
  Philadelphia, PA - 1/1/2008
• Fundus and fluorescein angiography 
  Albany, NY - 1/1/2008
• Update in retinal diseases 
  Albany, NY - 1/1/2007
• Five unusual cases: a day at the office 
  Hershey, PA - 1/1/2007
• How to manage vision loss in retinitis pigmentosa 
  1/1/2006
• Join now to see all